๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Influenza
Clinical trial register · China

Influenza Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Wuhan 4 Xiangyang 1 Shanghai 1 Hohhot 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing4 Wuhan4 Xiangyang1 Shanghai1 Hohhot1
All 13 locations
Target enrolment
to

Influenza trials in China

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anfluยฎ) Pregnant Women (AnFLU-PREG)
NCT07832201Influenza
Sinovac Biotech Co., Ltd
Phase 4
150
Changsha, Chengdu, Chongqing, Guangzhou, Nanjing, Wuhan
2026-10
By invitation
Smart Analysis and Decision-Making for Emerging Infectious Diseases
NCT07678619Emerging Infectious Diseases, COVID-19, Influenza, Mpox (Monkeypox)
Peking University
Not applicable
108
Beijing
2026-08-10
Not yet open
Study to Investigate the Efficacy and Safety of Apomivirยฎ
NCT01677689Influenza
Far East Bio-Tec Co., Ltd
Phase 2
196
2026-05-31
By invitation
A Study on Mucosal Specific IgA Immunokinetics After Administration of Nasal Spray Live Attenuated Influenza Vaccine
NCT07545564Influenza
DrugLAIV
Changchun BCHT Biotechnology Co.
Phase 4
200
Hohhot
2026-04-09
Not yet open
Effect of Oral Supplement on Influenza Vaccine Long-term Response
NCT07357467Influenza, Immunosenescence
Tsinghua University
Observational
30
Beijing
2026-03
Not yet open
Phase โ…ก Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07327398Influenza
Shanghai Institute Of Biological Products
Phase 2
1,200
Wuhan
2026-01-07
Recruiting
A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07302256Influenza
Shanghai Institute Of Biological Products
Phase 1
120
Wuhan
2025-12-16
Recruiting
Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting
NCT07236814Influenza
Capital Medical University
Phase 3
384
Beijing
2025-11-28
Active, closed
Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older
NCT07421050Influenza, Influenza Vaccine
DrugMF59
Ab&B Bio-tech Co., Ltd.JS
Phase 1
80
Xiangyang
2025-11-13
Active, closed
Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older
NCT07421037Influenza, Influenza Vaccine
DrugMF59
Ab&B Bio-tech Co., Ltd.JS
Phase 1
80
Shiyan
2025-11-13
Active, closed
Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine
NCT07232745Influenza
DrugLAIV
Jiangsu Province Centers for Disease Control and Prevention
Phase 4
60
Lianyungang
2025-10-12
Not yet open
Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting
NCT06762587Influenza, Influenza Prophylaxis, Nosocomial Infection
Capital Medical University
Not applicable
372
Beijing
2025-01-05
Recruiting
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
NCT06574503Influenza
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 3
748
Hanzhou
2024-12-01
Recruiting
Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection
NCT06667063COVID-19, Influenza
Zhongnan Hospital
Observational
130
Wuhan
2024-09-19
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/influenza

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Influenza.

How many Influenza trials are recruiting in China?

5 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 3 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Influenza), 15 studies
PhaseStudiesRecruitingShare
Phase 13120%
Phase 33320%
Phase 43020%
Not applicable2013.3%
Observational2113.3%
Phase 22013.3%

Most active sponsors

Lead sponsors with the most studies (Influenza)
Lead sponsorStudiesRecruiting
Ab&B Bio-tech Co., Ltd.JS20
Capital Medical University21
Shanghai Institute Of Biological Products21
Changchun BCHT Biotechnology Co.10
Far East Bio-Tec Co., Ltd10
Jiangsu Province Centers for Disease Control and Prevention10
Jiangxi Qingfeng Pharmaceutical Co. Ltd.11
Peking University10
Ruijin Hospital11
Sinovac Biotech Co., Ltd10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.